Loading insider details...
Beta
Latest Form 4 (May 16, 2025): Grant/Award of 14,000 VERA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 16, 2025 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 14,000 | n/a |
| Jun 7, 2024 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 12,500 | n/a |
| May 17, 2024 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 14,000 | n/a |
| Mar 26, 2024 | Vera Therapeutics, Inc. (VERA) | Sale | 32,756 | $1.41M |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 1,209,764 | $75.61M |
| Feb 1, 2024 | Vera Therapeutics, Inc. (VERA) | Purchase | 161,290 | $5.00M |
| Jan 4, 2024 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 3,519 | $47.5K |
| Jun 8, 2023 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 12,500 | n/a |
| May 12, 2023 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 20,000 | n/a |
| Feb 8, 2023 | Vera Therapeutics, Inc. (VERA) | Purchase | 285,714 | $2.00M |